SBH logo

Sangui Biotech International HMSE:SBH Stock Report

Last Price

€0.002

Market Cap

€419.8k

7D

0%

1Y

-77.8%

Updated

17 Jun, 2024

Data

Company Financials

Sangui Biotech International, Inc.

HMSE:SBH Stock Report

Market Cap: €419.8k

SBH Stock Overview

Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. More details

SBH fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Sangui Biotech International, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sangui Biotech International
Historical stock prices
Current Share Price€0.002
52 Week High€0.009
52 Week Low€0.002
Beta-0.33
1 Month Change0%
3 Month Change-20.00%
1 Year Change-77.78%
3 Year Change-90.48%
5 Year Changen/a
Change since IPO-99.94%

Recent News & Updates

Recent updates

Shareholder Returns

SBHDE BiotechsDE Market
7D0%-0.8%-1.6%
1Y-77.8%-13.0%6.8%

Return vs Industry: SBH underperformed the German Biotechs industry which returned -24.1% over the past year.

Return vs Market: SBH underperformed the German Market which returned 0.5% over the past year.

Price Volatility

Is SBH's price volatile compared to industry and market?
SBH volatility
SBH Average Weekly Movementn/a
Biotechs Industry Average Movement6.9%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.6%
10% least volatile stocks in DE Market2.4%

Stable Share Price: SBH's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine SBH's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995n/aThomas Striepewww.sanguibiotech.com

Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

Sangui Biotech International, Inc. Fundamentals Summary

How do Sangui Biotech International's earnings and revenue compare to its market cap?
SBH fundamental statistics
Market cap€419.80k
Earnings (TTM)-€40.48k
Revenue (TTM)€109.71k

3.8x

P/S Ratio

-10.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SBH income statement (TTM)
RevenueUS$117.44k
Cost of RevenueUS$0
Gross ProfitUS$117.44k
Other ExpensesUS$160.77k
Earnings-US$43.33k

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.00021
Gross Margin100.00%
Net Profit Margin-36.89%
Debt/Equity Ratio-72.3%

How did SBH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/17 03:01
End of Day Share Price 2024/03/20 00:00
Earnings2024/03/31
Annual Earnings2023/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sangui Biotech International, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution